paliperidone palmitate
paliperidone palmitate is a pharmaceutical drug with 34 clinical trials. Historical success rate of 96.6%.
Success Metrics
Based on 28 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.3%
28 of 31 finished
9.7%
3 ended early
0
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
European Long-acting Antipsychotics in Schizophrenia Trial
Clinical Trials (34)
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
European Long-acting Antipsychotics in Schizophrenia Trial
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection
The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia
A Comparison of Long-acting Injectable Medications for Schizophrenia
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
The Effect of Paliperidone Palmitate in Schizophrenia
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 34